Design and study of some novel ibuprofen derivatives with potential nootropic and neuroprotective properties

Ioanna C Siskou,Eleni A Rekka,Angeliki P Kourounakis,Michael C Chrysselis,Kariofyllis Tsiakitzis,Panos N Kourounakis
DOI: https://doi.org/10.1016/j.bmc.2006.10.056
2007-01-15
Abstract:Six novel ibuprofen derivatives and related structures, incorporating a proline moiety and designed for neurodegenerative disorders, are studied. They possess anti-inflammatory properties and three of them inhibited lipoxygenase. One compound was found to inhibit cyclooxygenase (COX)-2 production in spleenocytes from arthritic rats. The HS-containing compounds are potent antioxidants and one of them protected against glutathione loss after cerebral ischemia/reperfusion. They demonstrated lipid-lowering ability and seem to acquire low gastrointestinal toxicity. Acetylcholinesterase inhibitory activity, found in two of these compounds, may be an asset to their actions.
What problem does this paper attempt to address?